SOPHiA GENETICS Executive Chairman Camblong Jurgi sold 8,500 shares at $7.66 per share on September 10, 2026. The transaction left him with 3,435,822 shares, while its size represented about 0.2% of his prior holding, giving investors the disclosed scale of the ownership change.
Key Highlights
- Camblong Jurgi’s transaction used SEC transaction code S.
- His reported ownership after the transaction stood at 3,435,822 shares.
- Camblong Jurgi sold 8,500 SOPHiA GENETICS shares at $7.66 per share.
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Chairman Camblong Jurgi sold 8,500 shares at $7.66 per share on September 10, 2026. The transaction was reported under SEC transaction code S.
Transaction Recorded September 10
Jurgi held the Executive Chairman position at SOPHiA GENETICS SA when the transaction occurred. The reported transaction date was September 10, 2026. The source identifies the transaction with SEC transaction code S. The disclosed price was $7.66 for each share sold. The transaction involved 8,500 SOPHiA GENETICS SA shares.
Post-Transaction Ownership and Sale Proportion
Jurgi’s reported ownership after the transaction was 3,435,822 shares. The sale represented about 0.2% of his prior shares holding. The percentage is measured against his own position before the transaction, while the share count describes the position remaining afterward. Transaction code S denotes an open-market or private sale.
FAQs
Q: What did Camblong Jurgi sell in SOPHiA GENETICS?
A: Camblong Jurgi sold 8,500 SOPHiA GENETICS shares at $7.66 per share. The filing identifies him as the company’s Executive Chairman.
Q: How many SOPHiA GENETICS shares did Jurgi own afterward?
A: The filing reports that Jurgi owned 3,435,822 SOPHiA GENETICS shares following the transaction. This is his reported post-transaction ownership after the 8,500-share sale.
Q: What percentage of Jurgi’s holding did the insider sale represent?
A: The SOPHiA GENETICS insider sale represented about 0.2% of Jurgi’s prior shares holding. The percentage refers to his position before the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.